Opioid deprescribing is advised when risks of opioid use outweigh benefits. A tailored, patient-centered plan with gradual dose reduction, monitoring, and support can improve outcomes and reduce harm.

Alongside disclosing its financial performance for Q2 FY26, logistics major Delhivery announced its plans to foray into the ...

Background Although voting is recognised as a social determinant of health, the association between electoral participation ...

Disorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19 ...

Objective The FOURIER trial showed a benefit of the PCSK9 inhibitor evolocumab over placebo with respect to cardiovascular outcomes in patients with cardiovascular disease. However, we observed some ...

Physical therapy is routinely recommended for knee pain attributed to a degenerative meniscal tear, but its efficacy has not ...

DnaK/DnaJ or Trigger factor and find that chaperone dependence during primary biogenesis in vivo does not track with ...

Objectives The length and frequency of previous sickness absence (SA) spells have been shown to be associated with future SA. The aim was to examine if this pattern persisted during the COVID-19 ...

Objective This systematic review and meta-analysis aims to estimate the prevalence of high blood pressure (BP) and ...

Background Smoke-free and aerosol-free households (SAFHs) reduce exposure to secondhand smoke and aerosol and support ...

Background Tobacco use among United States (US) youth and young adults has declined from historic levels, but cannabis use ...